Nutritional influences on benign prostatic hyperplasia

Townsend Letter for Doctors and Patients, Dec, 2004 by Melvyn R. Werbach

8. Hoffman L et al. Carcinogenic effects of cadmium on the prostate of the rat. J Cancer Res Clin Oncol 109(3):193-9, 1985

9. Webber MM. Selenium prevents the growth stimulatory effects of cadmium on human prostatic epithelium. Biochem Biophys Res Commun 127(3):871-7, 1985

10. Wahba ZZ et al. Protective effects of selenium on cadmium toxicity in rats: role of altered toxicokinetics and metallothionein. J Toxicol Environ Health 38:171-82, 1993

11. Zaichick VY et al. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 29(5):565-74, 1997

12. Judd AM et al. Zinc acutely, selectively and reversibly inhibits pituitary prolactin secretion. Brain Res 294:190-2, 1984

13. Leake A et al. The effect of zinc on the 5-alpha-reduction of testosterone by the human prostate gland. J Steroid Biochem 20:651-5, 1984b

14. Leake A et al. Subcellular distribution of zinc in the benign and malignant human prostate: Evidence for a direct zinc androgen interaction. Acta Endocrinol 105:281-8, 1984c

15. Bandlish U et al. Plasma zinc level estimation in enlarged prostate. Indian J Pathol Microbiol 31(3):231-4, 1988

16. Schrodt GR et al. The concentration of zinc in diseased human prostate glands. Cancer 17:1555-66, 1964

17. Gyorkey F, Safo CS. In vitro 65-Zinc-binding capacities of normal, hyperplastic and carcinomatous human prostate gland. Exp Mol Pathol 8:216-24, 1968

18. Bush IM. Zinc and the prostate. Presented at the annual meeting of the American Medical Association. Chicago, 1974

by Melvyn R. Werbach, MD

4751 Viviana Drive * Tarzana, California 91356 USA

Phone 818-996-0076 * Fax 818-774-1575

Dr. Werbach cautions that the nutritional treatment of illness should be supervised by physicians or practitioners whose training prepares them to recognize serious illness and to integrate nutritional interventions safely into the treatment plan.